5 amino 1mq 10mg injection dosage Peptide Therapy 5 amino 1mq dosage subcutaneous

PubMed Heffernan, M.A., Thorburn, A.W., Fam, B., Summers, R., Conway-Campbell, B., Waters, M.J., & Ng, F.M

It was originally developed as a potential treatment for obesity by researchers at Monash University

The peptide is establishing its metabolic effects on fat tissue, but the total amount of fat oxidized over just 7-14 days is insufficient to produce measurable body composition changes

treatment should take place every 7 days for 3 weeks, then a monthly follow up shot for at least 3 months, then a follow up shot in 3 months time, dependant on exact level of symptoms

First, a bacterial reverse mutation test (Ames test) assessed AOD9604s mutagenic potential using four histidine-dependent auxotrophic mutants of Salmonella typhimurium (TA1535, TA1537, TA98, TA100) and one tryptophan-dependent auxotrophic mutant of Escherichia coli (WP2 uvrA), using both plate incorporation and pre-incubation methods at doses of 0, 1.6, 8, 40, 200, 1,000, and 2,000 g AOD9604/plate